LQ-38

LQ-38 is a potent, orally bioavailable soluble epoxide hydrolase (sEH) inhibitor (IC50 = 5.2 nM) . It demonstrates anti-inflammatory and analgesic efficacy in established rodent models, including rat paw edema, murine acute pancreatitis, and acetic acid-induced writhing, supporting its use in pain and inflammation research.